You have 9 free searches left this month | for more free features.

Lymphoma, Mantle-Cell

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Patient Perspectives in Mantle Cell Lymphoma Clinical Research

Not yet recruiting
  • Mantle Cell Lymphoma
    • San Francisco, California
      Power Life Sciences
    Sep 15, 2023

    Lymphoma, Mantle-Cell Trial in Shanghai (Zanubrutinib, Rituximab, Bendamustin)

    Not yet recruiting
    • Lymphoma, Mantle-Cell
    • Shanghai, Shanghai, China
      Ruijin Hospital
    Nov 14, 2023

    Mantle-cell Lymphoma Trial (Polatuzumab, bendamustin und rituximab)

    Not yet recruiting
    • Mantle-cell Lymphoma
    • Polatuzumab, bendamustin und rituximab
    • (no location specified)
    May 11, 2023

    Mantle Cell Lymphoma Trial in Miami, Houston (Zanubrutinib, Tafasitamab)

    Not yet recruiting
    • Mantle Cell Lymphoma
    • Miami, Florida
    • +1 more
    Aug 31, 2023

    Mantle Cell Lymphoma, Lymphoma, Mantle Cell Trial run by the NCI (EPOCH-R, GM-CSF, Idiotype vaccine)

    Completed
    • Mantle Cell Lymphoma
    • Lymphoma, Mantle Cell
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jan 4, 2023

    Mantle Cell Lymphoma Trial (Acalabrutinib, Rituximab)

    Not yet recruiting
    • Mantle Cell Lymphoma
    • (no location specified)
    Oct 31, 2022

    Mantle Cell Lymphoma Trial (Zanubrutinib, Rituximab)

    Not yet recruiting
    • Mantle Cell Lymphoma
    • (no location specified)
    Nov 22, 2022

    Mantle Cell Lymphoma Refractory Trial (Ibrutinib, Venetoclax, Navitoclax)

    Not yet recruiting
    • Mantle Cell Lymphoma Refractory
    • (no location specified)
    May 16, 2023

    Mantle Cell Lymphoma, Mantle Cell Lymphoma Refractory Trial (Glofitamab, Pirtobrutinib, Obinutuzumab)

    Not yet recruiting
    • Mantle Cell Lymphoma
    • Mantle Cell Lymphoma Refractory
    • (no location specified)
    Apr 18, 2023

    Follicular Lymphoma, B-Cell Lymphoma, Mantle Cell Lymphoma Trial in New York (Tazemetostat Pill)

    Not yet recruiting
    • Follicular Lymphoma
    • +3 more
    • Tazemetostat Pill
    • New York, New York
      Weill Cornell Medicine/NewYork-Presbyterian Hospital
    Jun 28, 2023

    Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Houston (Low Dose Radiation Therapy)

    Recruiting
    • Recurrent Mantle Cell Lymphoma
    • Refractory Mantle Cell Lymphoma
    • Low Dose Radiation Therapy
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 30, 2023

    Mantle Cell Lymphoma, Ketogenic Dieting Trial in New York (Ketogenic Diet)

    Recruiting
    • Mantle Cell Lymphoma
    • Ketogenic Dieting
    • Ketogenic Diet
    • New York, New York
      Weill Cornell Medicine
    Oct 17, 2022

    Follicular Lymphoma, Mantle Cell Lymphoma Trial in Rouen (Determination of COVID-19 vacciantion efficacy)

    Completed
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • Determination of COVID-19 vacciantion efficacy
    • Rouen, France
      Centre Henri Becquerel
    Dec 22, 2022

    Acute Myeloid Leukemia, Lymphoma, Mantle-Cell Trial (PEP07)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Lymphoma, Mantle-Cell
    • (no location specified)
    Dec 22, 2022

    Lymphoma Trial in Beijing, Shanghai City, Seoul (Obinutuzumab, Glofitamab, Rituximab)

    Recruiting
    • Lymphoma
    • Beijing, China
    • +2 more
    Oct 12, 2023

    Mantle Cell Lymphoma Trial (drug, biological, other, procedure)

    Not yet recruiting
    • Mantle Cell Lymphoma
    • (no location specified)
    Jul 26, 2023

    Blastoid Variant Mantle Cell Lymphoma, CCND1 Protein Overexpression, CD20 Positive Trial in Houston (Acalabrutinib, Venetoclax)

    Recruiting
    • Blastoid Variant Mantle Cell Lymphoma
    • +8 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 5, 2022

    Mantle Cell Lymphoma Trial in Houston (Ibrutinib)

    Recruiting
    • Mantle Cell Lymphoma
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 1, 2022

    Mantle Cell Lymphoma Recurrent Trial in Melbourne (ibrutinib and Tisagenlecleucel)

    Active, not recruiting
    • Mantle Cell Lymphoma Recurrent
    • ibrutinib and Tisagenlecleucel
    • Melbourne, Victoria, Australia
      Peter Mac Callum Cancer Centre
    Nov 4, 2022

    Mantle Cell Lymphoma Trial in Houston (Acalabrutinib)

    Recruiting
    • Mantle Cell Lymphoma
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 22, 2022

    Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma (MCL), Relapsed Mantle Cell Lymphoma Trial (BGB-11417)

    Not yet recruiting
    • Mantle Cell Lymphoma
    • +2 more
    • (no location specified)
    Jul 25, 2022

    Lymphoma, Mantle-Cell, Lymphoma, Lymphoproliferative Disorders Trial (Zilovertamab, Ibrutinib, Placebo)

    Not yet recruiting
    • Lymphoma, Mantle-Cell
    • +7 more
    • (no location specified)
    Jun 21, 2022

    Recurrent Refractory Mantle Cell Lymphoma

    Recruiting
    • Mantle Cell Lymphoma
      • Beijing, Beijing, China
        Peking University Third Hospital
      Aug 1, 2022

      Diffuse Large B Cell Lymphoma, Transformed Indolent Non-Hodgkin's Lymphoma, Follicular Lymphoma Trial (FT596, Cyclophosphamide,

      Withdrawn
      • Diffuse Large B Cell Lymphoma
      • +4 more
      • (no location specified)
      Jun 28, 2023

      Newly Diagnosed Mantle Cell Lymphoma Trial in Zhengzhou (Rituximab)

      Recruiting
      • Newly Diagnosed Mantle Cell Lymphoma
      • Zhengzhou, Henan, China
        Department of Oncology, The First Affiliated Hospital of Zhengzh
      Aug 17, 2022